Blood pressure, C-reactive protein, and risk of future cardiovascular events

Gavin J Blake1, Nader Rifai, Julie E Buring

  • 1Center for Cardiovascular Disease Prevention and the Donald W. Reynolds Center for Cardiovascular Research, Boston, Mass, USA. gblake@mater.ie

Circulation
|November 26, 2003
PubMed

Insights

High blood pressure and C-reactive protein (CRP) independently predict cardiovascular events. Combining elevated blood pressure and CRP significantly increases cardiovascular risk, highlighting their additive prognostic value for heart health.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Public Health

Background:

  • Emerging evidence links elevated blood pressure to vascular inflammation.
  • C-reactive protein (CRP) is a key inflammatory marker associated with cardiovascular disease.
  • Understanding the interplay between blood pressure and inflammation is crucial for cardiovascular risk assessment.

Purpose of the Study:

  • To investigate the relationship between blood pressure, CRP levels, and the incidence of first cardiovascular events in women.
  • To determine if CRP provides incremental prognostic value for cardiovascular events across different blood pressure categories.
  • To assess the combined and independent contributions of blood pressure and CRP to cardiovascular risk.

Main Methods:

  • Prospective cohort study involving 15,215 women.
  • Baseline assessment of blood pressure and C-reactive protein (CRP) levels.
  • Follow-up for incident first cardiovascular events over a median of 8.1 years.
  • Statistical analyses including cross-sectional and prospective analyses, hazard ratios, and risk factor adjustments.

Main Results:

  • A significant positive trend was observed between increasing blood pressure categories and median CRP levels at baseline (P < 0.0001).
  • Both elevated CRP levels (≥3 mg/L) and higher blood pressure categories were independent predictors of future cardiovascular events.
  • The combination of high blood pressure (≥160/95 mm Hg) and high CRP (≥3 mg/L) was associated with a substantially increased hazard ratio (8.31) for cardiovascular events.
  • Risk factor-adjusted analyses showed additive effects: high CRP/low blood pressure (HR 1.87), low CRP/high blood pressure (HR 2.54), and high CRP/high blood pressure (HR 3.27).

Conclusions:

  • Blood pressure and CRP are independent determinants of cardiovascular risk.
  • The predictive value of blood pressure and CRP for cardiovascular events is additive.
  • Measuring both blood pressure and CRP can enhance cardiovascular risk stratification.
Abstract

Related Concept Videos

Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
5.2K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
760